Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbCellera Biologics

3.41
-0.0600-1.73%
Post-market: 3.440.0300+0.88%19:59 EDT
Volume:8.76M
Turnover:29.47M
Market Cap:1.02B
PE:-6.00
High:3.55
Open:3.50
Low:3.24
Close:3.47
Loading ...
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Dec 07, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 04, 2021

Major Issues Report

8-K - Current report
Sep 23, 2021

Major Issues Report

8-K - Current report
Sep 15, 2021

Major Issues Report

8-K - Current report
Aug 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2021

Major Issues Report

8-K - Current report
Jul 13, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
Jun 17, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 10, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 17, 2021

Major Issues Report

8-K/A [Amend] - Current report
May 14, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Major Issues Report

8-K - Current report